Alnylam Pharmaceuticals/ US02043Q1076 /
| 9/19/2024 9:59:55 PM | Chg. +3.48 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 276.56USD | +1.27% | 30,473 Turnover: 8.43 mill. |
-Bid Size: - | -Ask Size: - | 35.48 bill.USD | - | - |
Time & Sales
| Date | Time | Last | Volume |
|---|---|---|---|
| 9/19/2024 | 9:59:55 PM | 276.56 | 4 |
| 9/19/2024 | 9:59:52 PM | 276.43 | 10 |
| 9/19/2024 | 9:59:52 PM | 276.16 | 24 |
| 9/19/2024 | 9:59:50 PM | 276.02 | 25 |
| 9/19/2024 | 9:59:50 PM | 276.02 | 25 |
| 9/19/2024 | 9:59:50 PM | 276.04 | 25 |
| 9/19/2024 | 9:59:50 PM | 276.04 | 25 |
| 9/19/2024 | 9:59:50 PM | 276.04 | 25 |
| 9/19/2024 | 9:59:45 PM | 276.14 | 100 |
| 9/19/2024 | 9:59:34 PM | 276.32 | 100 |
| 9/19/2024 | 9:59:20 PM | 276.28 | 5 |
| 9/19/2024 | 9:59:12 PM | 276.15 | 44 |
| 9/19/2024 | 9:59:01 PM | 276.15 | 36 |
All quotes in USD
